Syndax Pharmaceuticals Inc

SNDX · Nasdaq · SIC 2834: Pharmaceutical Preparations
193
SEC Filings

Business Summary

1 Item 1A. Risk Factors 21 Item 1B. Unresolved Staff Comments 57 Item 1C. Cybersecurity 57 Item 2. Properties 59 Item 3. Legal Proceedings 59 Item 4. Mine Safety Disclosures 59 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuers Purchases of Equity Securities 60 Item 6. [Reserved] 62 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 63 Item 7A. Quantitative and Qualitative Disclosures about Market Risk 75 Item 8...

Next Earnings

Q2 FY2026 — expected 2026-08-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSNDXdiscussed_in_filing Cybersecurity
topic_mentionSNDXdiscussed_in_filing Cybersecurity
topic_mentionSNDXdiscussed_in_filing Cybersecurity
topic_mentionSNDXdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-076536EDGAR77K words
2025-03-032024-12-310000950170-25-030394EDGAR—
2024-02-272023-12-310000950170-24-021253EDGAR—
2023-02-282022-12-310000950170-23-005079EDGAR—
2022-03-012021-12-310001564590-22-008112EDGAR—
2021-03-122020-12-310001564590-21-012607EDGAR—
2020-03-052019-12-310001564590-20-009016EDGAR—
2019-03-072018-12-310001564590-19-006772EDGAR—
2018-03-082017-12-310001564590-18-004911EDGAR—
2017-03-142016-12-310001193125-17-081863EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-032025-09-300001193125-25-262521EDGAR22K words
2025-08-042025-06-300000950170-25-101985EDGAR—
2025-05-052025-03-310000950170-25-063518EDGAR—
2024-11-052024-09-300000950170-24-121439EDGAR—
2024-08-012024-06-300000950170-24-089241EDGAR—
2024-05-082024-03-310000950170-24-055053EDGAR—
2023-11-022023-09-300000950170-23-058165EDGAR—
2023-08-032023-06-300000950170-23-037943EDGAR—
2023-05-082023-03-310000950170-23-018806EDGAR—
2022-11-032022-09-300000950170-22-021848EDGAR—
2022-08-082022-06-300000950170-22-015523EDGAR—
2022-05-092022-03-310001564590-22-018873EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001193125-26-076522EDGAR4K words
2026-01-120001193125-26-010486EDGAR—
2025-12-190001193125-25-326961EDGAR—
2025-11-030001193125-25-262509EDGAR—
2025-10-240001193125-25-250052EDGAR—
2025-08-040000950170-25-101974EDGAR—
2025-06-260000950170-25-090205EDGAR—
2025-05-160000950170-25-073555EDGAR—
2025-05-050000950170-25-063514EDGAR—
2025-03-030000950170-25-030392EDGAR—

193 total filings indexed. 161 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001395937
TickerSNDX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c9d152775621c07fca8eaa99635515974859366361fc24580b0cee89b3a596e2
parent: ffd22853d7be7ed6546a35ab77e8b2c24ab426155aca1ff469b818e803a1f653
content hash: e140fef8a0efd421a14cd49723e3568a9ff2b301613ec8d8f4c8125a4215a3ec
signed: 2026-04-13T04:47:31.144Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf